Infectious Diseases – News and Features

GI-directed therapy to treat the common life threatening complication of hematopoietic stem cell transplantation.

BioMerieux to advance infection control and process assurance capabilities.

Data suggest the potential for targeting the key proteins, RANK Ligand and sclerostin, for bone loss conditions.

Zhejiang University to use GeneChip® microarray technology to detect, classify, manage and treat cancer and infectious diseases.

Insights from the study could help guide similar adult stem cell transformations in other cell types in the future.

Company researchers to present data on discovery of AN2690, AN0128 at American Chemical Society meeting.

Study describes a mechanism that extends the number of antigenic peptides that can be produced from a single protein.

The scientists designed a group of compounds that can block the chemical signals that the bacteria use to communicate.

The SBIR grant will provide Alnylam with approximately $590,000 in funding over a one-year period.

The focus of the agreement is to extend IIBM's Stem Cell Liver Regeneration procedure to the western world.